Leading Medicine Guide Logo

Frailty Syndrome — Understanding and Treating Frailty in Old Age

Leading Medicine Guide Editors
Author
Leading Medicine Guide Editors
Two 82-year-old female patients, the same history, the same operation — a total hip replacement. One stands at the walking frame on the third day, walks in the corridor on the seventh, is discharged after two weeks. The other develops delirium on the second day, pneumonia on the fifth, and on the tenth she is bedridden. By the end of the month she is in a nursing home. The differences were barely visible in the medical record — but they were predictable.

The technical term for the difference is frailty. It is perhaps the most important concept in modern geriatric medicine, and at the same time the one most frequently overlooked in routine clinical practice.

As a geriatrician, the question I ask myself before every major treatment decision is not: “How old is the patient?” but: “How frail is she?” These are two completely different questions — and the answer to the second often decides the prognosis.

Brief overview:

Frailty refers to a state of reduced reserve capacity and increased vulnerability. Not every older person is frail, and not every clinical picture in old age means frailty. The decisive feature is that even small triggers such as an infection, a fall or an operation lead to a disproportionately severe deterioration. Around 10 to 15 percent of people over 65 are frail, and among those over 85 even 30 to 50 percent. The good news: frailty is not an inevitable fate but a dynamic state — with targeted strength training, protein-rich nutrition, medication review and social activity, reserve can be regained. This article explains the two most important diagnostic models (the Fried phenotype and the Clinical Frailty Scale), why frailty is the most important question before any operation in old age and what specifically helps.

Article overview

What is frailty?

Frailty describes a clinical state of diminished physiological reserves. A frail person can still function under everyday conditions — but the slightest stressor tips them into a crisis that a non-frail person would absorb without difficulty. In geriatrics, frailty is therefore the decisive link between chronological age and biological age. An overview of the entire field is provided in the article on geriatrics and medicine for the elderly.

Three distinctions are important:

  • Frailty is not the same as multimorbidity: One can have many illnesses and at the same time not be frail — and vice versa.
  • Frailty is not the same as disability: Disability describes what someone can no longer do. Frailty describes how well someone can cope with a stressor.
  • Frailty is not the same as sarcopenia: Sarcopenia (muscle loss) is a central building block, but frailty encompasses more: cognitive, nutritional and social dimensions as well. Cognitive changes such as mild cognitive impairment (MCI) can intensify frailty and vice versa.

On the specific significance of muscle loss in old age: Sarcopenia — recognizing and stopping muscle loss.

Frailty syndrome

The two most important diagnostic models

Two validated models dominate clinical practice. Both have their justification, in different settings.

The Fried phenotype

In 2001, Linda Fried and colleagues defined five criteria. Anyone meeting three or more is considered frail; one to two as pre-frail; none as robust.

  • Unintentional weight loss: More than 4.5 kilograms or 5 percent of body weight in the past year. This weight loss is frequently a sign of malnutrition in old age.
  • Exhaustion: Subjectively reported exhaustion on three or more days per week.
  • Weakness: Reduced grip strength, measured with a dynamometer.
  • Slowness: Slowed walking speed over four meters.
  • Low physical activity: Markedly reduced everyday activity, which in extreme cases can culminate in immobility in old age.

The Fried phenotype is particularly useful in research and in preoperative evaluation, because it can be measured objectively and reproducibly.

The Clinical Frailty Scale (CFS)

The CFS, developed by Kenneth Rockwood, is a 9-point scale that can be assessed clinically within a few minutes — without any special equipment. It ranges from CFS 1 (“very fit”) through CFS 5 (“mildly frail”) to CFS 9 (“terminally ill”).

The CFS has become established worldwide because it is immediately available in hectic clinical situations — emergency department, intensive care unit, preoperative clinic — and nevertheless provides highly significant prognostic information. In numerous studies, a CFS above 5 is associated with markedly increased mortality, longer length of stay and a higher rate of functional loss after hospitalization. The structured frailty screening describes which tests are used in concrete terms.

As a patient or relative, you can ask about the Clinical Frailty Scale before any major treatment decision: “Was the CFS assessed, and what value did it produce?” This is not a specialist question — it is a fundamental question of any modern medicine for the elderly.

How common is frailty?

  • 65- to 74-year-olds: About 4 to 8 percent are frail, a further 30 percent pre-frail.
  • 75- to 84-year-olds: Around 15 percent frail.
  • Over-85-year-olds: 30 to 50 percent frail.
  • In nursing homes: Over 60 percent of residents meet frailty criteria.

Frailty is thus one of the most common syndromes in medicine for the elderly — and one of the least frequently documented. Many discharge letters mention diabetes in old age, hypertension and atrial fibrillation in old age — but not a word about frailty. That is a systematic gap.

Why frailty is so clinically important

Frailty is not merely an epidemiological observation — it changes the entire level of clinical decision-making:

  • Surgical planning: The frailty-adjusted risk assessment is superior to the conventional ASA score. A CFS of 5 or higher should factor into every risk-benefit consideration for elective procedures. Details on this are provided in the article on the surgical risk in old age.
  • Drug therapy: In frail patients the benefit-risk ratios shift: some guideline-compliant therapy (strict blood sugar control, aggressive blood pressure reduction) becomes a net harm in frailty. The topic of polypharmacy in old age also plays a central role here.
  • Rehabilitation: Frail patients benefit particularly — and specifically — from early geriatric rehabilitation. Standard protocols often do not take hold.
  • Prognosis: In many cohort studies frailty is the strongest single predictor of 1-year mortality — stronger than many specific diagnoses, including existing heart failure in old age.
  • Risk of delirium in hospital: After procedures or acute illnesses, frail patients develop delirium considerably more often. Targeted delirium prevention is therefore part of the standard in geriatric care.
  • End-of-life decision-making: In pronounced frailty (CFS 7–8) treatment goals shift toward quality of life and symptom control. These conversations must be conducted early — and should ideally be safeguarded by an advance directive.

On preoperative assessment and risk modification: Surgical risk in old age.

How early geriatric rehabilitation works specifically in frail patients: Early geriatric rehabilitation.

Causes: Why does one become frail?

Frailty is multifactorial. The most important mechanisms — and thus the most important points of intervention for prevention and therapy — are:

  • Sarcopenia: The age-related loss of muscle mass and muscle strength. Without targeted training, about 1 to 2 percent per year from the age of 50. More on this in the article on sarcopenia.
  • Malnutrition: Protein deficit in particular: the recommended daily protein intake for older people (1.0 to 1.2 g per kg of body weight) is not reached by most. Detailed background is provided in the article on malnutrition in old age.
  • Chronic inflammatory burden: Elevated levels of interleukin-6, CRP, TNF-alpha — a phenomenon often referred to as inflammaging.
  • Hormonal changes: Decline of testosterone, growth hormone, vitamin D. A confirmed vitamin D deficiency is closely linked with osteoporosis in old age.
  • Lack of physical activity: The most important modifiable cause. Every day with less activity makes one frail — a vicious circle that in extreme cases leads to immobility in old age.
  • Social isolation: Loneliness is an independent risk factor — biologically measurable, not only psychologically relevant. There are also close interactions with depression in old age.
  • Multimorbidity and polypharmacy: Not identical with frailty, but one of the strongest driving forces. On reducing medication in old age: deprescribing.

Therapy: Frailty is not necessarily irreversible

The most important misconception: that frailty is a final state. The evidence speaks against this. Studies show that about one third of pre-frail patients return to the robust state within a year — and even in pronounced frailty, stabilization or partial reversion is possible when the right interventions work together.

What the evidence supports

  • Progressive strength training: By far the strongest single lever. Studies show strength gains of 30 to 100 percent within a few months — even in 85- and 90-year-olds.
  • Protein-rich nutrition: With a focus on distribution across the day. Protein-rich breakfasts are more important than a single large evening meal.
  • Vitamin D supplementation in confirmed deficiency: Not across the board for everyone. A deficiency is frequently associated with osteoporosis in old age and an increased risk of falls.
  • Medication review: Deprescribing not only reduces side effects but frequently improves energy and muscle strength directly.
  • Treatment of hidden illnesses: Anemia, thyroid disorders, depression in old age, obstructive sleep apnoea syndrome — each is a potential amplifier of frailty. An unrecognised dementia in old age or mild cognitive impairment (MCI) can also obscure the frailty picture.
  • Fall prevention: Since frail patients carry a markedly increased risk of falls — with consequences such as a femoral neck fracture in old age — targeted fall prevention is among the most important accompanying measures.
  • Social activity: Participation, volunteering, structured group programs — measurably effective.
  • Geriatric assessment as a structure: The geriatric assessment is not a single intervention but the tool with which the right interventions are identified. It records mobility, cognition, nutritional status, fall risk and medication systematically.

What a targeted nutritional intervention in older people looks like: Malnutrition in old age.

Why lack of movement and immobility are more dangerous than many think: Immobility in old age.

Recognizing frailty: What can relatives do?

For relatives who want to assess the condition of an elderly family member realistically, the following everyday observations help:

  • Can he or she walk 400 meters without a break?
  • Climb a flight of stairs without a handrail?
  • Rise from a deep armchair without bracing on the arms?
  • Carry a shopping bag with a few groceries?
  • Has there been unintentional weight loss in the last six months?
  • Has activity noticeably reduced compared with the previous year?
  • Does the person report persistent exhaustion?
  • Are there indications of urinary incontinence in old age? This frequently concealed symptom too can be a sign of declining physical reserves.

If several of these questions are answered with No, or Yes on the final points, a geriatric work-up is worthwhile. Initial pointers are provided by the structured frailty screening.

When should you see a geriatrician?

Frailty is not always obvious. The following situations are good occasions to obtain a geriatric second opinion:

  • Before any elective major operation in patients over 75 — the surgical risk in old age depends decisively on the frailty status.
  • After a hospital stay with visible functional loss
  • In the case of repeated falls or newly occurring gait unsteadiness — further information can be found in the article on falls in old age
  • In the case of unintentional weight loss of over 5 percent in six months
  • In the case of polypharmacy with five or more long-term medications
  • When a serious diagnosis such as cancer or heart failure in old age calls for treatment decisions

On these questions the geriatrician brings a perspective that is often missing in organ-based specialties: the question of how resilient the patient is as a whole system — and which interventions pay off before the next stressor comes.

Which tests are used exactly in frailty screening is described in our article Frailty screening — practical implementation.

Medical spectrum

Specializations

References

  • Fried LP, Tangen CM, Walston J et al. (2001): Frailty in older adults: evidence for a phenotype. Journals of Gerontology Series A. DOI: 10.1093/gerona/56.3.M146
  • Rockwood K, Song X, MacKnight C et al. (2005): A global clinical measure of fitness and frailty in elderly people. Canadian Medical Association Journal.
  • Dent E, Morley JE, Cruz-Jentoft AJ et al. (2019): Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. Journal of Nutrition, Health & Aging. DOI: 10.1007/s12603-019-1273-z
  • Hoogendijk EO, Afilalo J, Ensrud KE et al. (2019): Frailty: implications for clinical practice and public health. The Lancet. DOI: 10.1016/S0140-6736(19)31786-6